This information
collection is approved for use until 7/31/90. These information
collection requirements are contained in the rules implementing the
Infant Formula Act of 1980 and as such represents a 3504(h)
information collection. By its next submission, FDA should initiate
rulemaking to bring Section 106.100(c) into accordance with 5 CFR
1320.7(u)(1) and (2).
Inventory as of this Action
Requested
Previously Approved
07/31/1991
07/31/1991
10
0
0
37,555
0
0
0
0
0
INFANT FORMUL LABELING AND INFANT
FORMULA QUALITY CONTROL PROCEDURES ARE NECESSARY T ASSURE THAT
NUTRIENT LEVELS OF INFANT FORMULA ARE DECLARED ON THE LABE AND MEET
THE REQUIREMENTS OF THE INFANT FORMULA ACT. THE REGULATIONS AFFECT
INFANT FORMULA MANUFACTURERS/CONSUMERS.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.